BICO Group

BICO Group
About Us
Change country

Follow us:
Share:
Subscribe:

About Us

Founded in 2016, BICO (formerly CELLINK) is the leading Bio Convergence company in the world by combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better. With a focus on the application areas of bioprinting, multiomics, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. We create the future of health. The Group’s products are trusted by more than 2,000 laboratories, including all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 9,000 publications. BICO is listed on Nasdaq Stockholm under BICO. www.bico.com

DISPENDIX welcomes Petros Apostolopoulos as new CEO to strengthen position as leading liquid handling and lab automation company

Mon, Aug 23, 2021 08:00 CET

Effective August 2, 2021, Petros Apostolopoulos, who has a strong track record of launching high-tech products for Life Science automation, has taken over operations.DISPENDIX , a BICO company, announces the appointment of Petros Apostolopoulos as the new company CEO. Petros will lead product, growth, market expansion and overall business operations and will continue to drive the strategy and focus of DISPENDIX to deliver customer success. Before joining DISPENDIX, Petros served over 15 years at Festo, a global leader in automation technology,

There are no items matching the current filter

There are no more items matching the current filter

Share

About Us

Links

DISPENDIX welcomes Petros Apostolopoulos as new CEO to strengthen position as leading liquid handling and lab automation company